Preview

Pediatric pharmacology

Advanced search
Vol 3, No 4 (2006)
View or download the full issue PDF (Russian)

ORIGINAL ARTICLES

10-16 527
Abstract
To investigate the role of the reninangiotensin system genes polymorphisms in develop and progression of nephrotic syndrom (NS) in children we determined the genotypes of angiotensin converting enzyme (ACE), angiotensinogen (AGT) and angiotensin ii receptor (ATII-R) of 1 type in 80 russian children with ns including and 15 children with chronic renal failure (CRF). Genotype frequencies did not differ between patients with ns and controls (n = 165). The distribution of ace, AGT and ATII-R 1 type genotypes was similar among ns sub groups, such as focal segmental glomerulosclerosis (FSGS) (n = 18), steroid-sensitive nephrotic syndrome (n = 32), nephrotic syndrome with hypertension and hemoturia (n = 22) and with control group. When ns subjects with CRF (n = 15) were compared with control, the prevalence of ace DD genotype was significantly higher (47% VS 21%; χ2 = 4,44; p < 0,05). Our results indicate that the DD genotype ace may be a factor of risk for the dеvеlopment of progressive renal impairment in the children with nephrotic syndrome. The analysis of treatment's effect with inhibitor of ace in groups patients with steroid resistant NS (SRNS) demonstrated decreasing of renoprotective effect of this drugs in patients with id and dd genotypes com? Pared with ii genotype: the degree of blood pressure, proteinuria and the rate of glomerular filtration decrease was significantly lower (55,46 ± 9,25 VS 92,74 ± 25; р < 0,05) in these patients.
Key words: nephrotic syndrom, chronic renal failure, polymorphism of genes, renin-angiotensin system.
17-21 476
Abstract
Information about an infection caused by human herpes virus type 6, its' epidemiology, pathogenesis and clinical variants, is reviewed. Clinical cases, diagnosed at a time of study, are briefly reviewed.
Key words: human herpes virus type 6, exanthema subitum (roseola infantum), fever of unknown origin, mononucleosis like syndrome, meningoencephalitis, children.

REVIEW

32-41 10997
Abstract
Anti inflammatory medications are the basis for pathogenetic treatment of allergic diseases. The review covers description of the most studied and efficient medication of leukotriene receptors' antagonist category montelukast. Specific and reversible antagonism to leukotriene receptors sets two most important effects of this medication: treatment of inflammatory process and influence tu muscular cells of bronchi. The article reviews in detail the possibility of applying montelukast in allergology as a basis therapy, peculiarities of its pharmacokinetics, pharmacodynamics and safety. Its advantages and disadvantages for monotherapy of bronchial asthma and allergic rhinitis are discussed, as well as the role of this category of medications in combined therapy of bronchial asthma and allergic rhinitis, and its influence to exercise induced bronchoconstriction.
Key words: antagonists of leukotriene receptors, montelukast, bronchial asthma, allergic rhinitis, treatment, children.

CLINICAL RECOMMENDATIONS

LECTURE

42-49 441
Abstract
Information on clinical use of long acting β2-adrenergic agonist formoterol in children with asthma is presented. Pharmacokinetics and pharmacodymanics are scrutinized in detail. Combined therapy for asthma with formoterol and inhaled corticosteroids is spotlighted.
Key words: formoterol, asthma, children.
50-55 1011
Abstract
Issues of etiology, pathogenesis, epidemiology, diagnostics and treatment are inspected from the present day point of view focusing on novel screening methods used for early diagnostics of the disease. The article gives grounded key principles of complex treatment including rational use of antibacterial and mucolytic agents.
Key words: cystic fibrosis, diagnostics, treatment, children.
56-62 484
Abstract
Of intercurrent infections in children with allergic pathology use of topical bacterial lyzates as a therapy for intercurrent infections in children with allergic pathology is reviewed basing on publications and personal clinical experience. Deficient mucous immunity has been established in allergic children with recurrent and acute upper respiratory tract and herpes virus infections, thus providing base for use of immunomodulators as a part of complex treatment for this group of patients.
Key words: children, allergic diseases, respiratory tract infections, stomatitis, prophylaxis, treatment, immunomodulators.
66-68 777
Abstract
In article are persented the results of clinical study of efficacy of fluconazole (mucoflucan) used to treat otomycosis in children. According to the results of the study fluconazole has effectively surpressed the mycotic infection and ameliorated symptoms of the disease, promoting earlier recovery.
Key words: otomycosis, treatment, children, fluconazole.

For Pediatricians' Practice

63-64 1156
Abstract
A study of use of ibuprofen in cases of viral upper respiratory tract infections (Vuri) in children of early childhood has proved its' safety and efficacy. This medical agent has not only terminate fever but also diminished some other symptoms of Vuri.
Key words: ibuprofen, viral upper respiratory tract infections, children.
69-79 889
Abstract

This clinical practice guideline formulates recommendations for health care providers regarding the diagnosis, evaluation, and treatment of children, ages 1 to 21 years, with uncomplicated acute, subacute, and recurrent acute bacterial sinusitis. Three specific issues were considered: 1) evidence for the efficacy of various antibiotics in children; 2) evidence for the efficacy of various ancillary, nonantibiotic regimens; and 3) the diagnostic accuracy and concordance of clinical symptoms, radiography (and other imaging methods), and sinus aspiration.

It is recommended that the diagnosis of acute bacterial sinusitis be based on clinical criteria in children ≤6 years of age who present with upper respiratory symptoms that are either persistent or severe. Although controversial, imaging studies may be necessary to confirm a diagnosis of acute bacterial sinusitis in children >6 years of age. Computed tomography scans of the paranasal sinuses should be reserved for children who present with complications of acute bacterial sinusitis or who have very persistent or recurrent infections and are not responsive to medical management.

There were only 5 controlled randomized trials and 8 case series on antimicrobial therapy for acute bacterial sinusitis in children. However, these data, plus data derived from the study of adults with acute bacterial sinusitis, support the recommendation that acute bacterial sinusitis be treated with antimicrobial therapy to achieve a more rapid clinical cure. Children with complications or suspected complications of acute bacterial sinusitis should be treated promptly and aggressively with antibiotics and, when appropriate, drainage. Based on controversial and limited data, no recommendations are made about the use of prophylactic antimicrobials, ancillary therapies, or complementary/alternative medicine for prevention and treatment of acute bacterial sinusitis.

Key words: sinusitis, treatment, management, children.

DEBATABLE ISSUES OF PHARMACOTHERAPY

AN EDITORIAL ARTICLE

6-9 500
Abstract
The author presents serological criteria for verification of pertussis in children 2–14 years with chronic cough. The pertussis was clinically and serologically confirmed in 52,5% children with chronic cough in absence of other common causes of cough. The most children aged 2–4 years had violation from re Commended vaccination schedule or rejection from pertussis vaccination. In elder groups the frequency of pertussis was equal in children vaccinated according to national immunization calendar and with violation from the calendar. The author concludes about necessity to introduce second booster dose of pertussis vaccine in age 6 years and about wide using of acellular vaccines as for booster as for primary vaccination of children from risk groups.
Key words: pertussis, diagnostics, prophylaxis, vaccines, children.

JUBILEE



ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)